Experts share the latest research in glaucoma
CERA has the largest research group in Australia performing basic science research into the causes and treatments of optic nerve damage and vision loss in glaucoma.
The leading cause of irreversible blindness worldwide, glaucoma affects an estimated 300,000 Australians. Alarmingly, half of these people do not know they have the condition and with no early warning signs, glaucoma often remains undiagnosed until significant, permanent vision loss has already occurred.
This information session is a great opportunity for members of the public to learn more about the recent developments in glaucoma research and management. Topics covered will include an update on eye drops, visual field testing, the importance of screening and early detection and the use of new imaging techniques.
Hosted by CERA’s Managing Director and Head of the Glaucoma Research Unit, Professor Jonathan Crowston, the event includes presentations by Dr Jonathan Ruddle, Research Fellow, Mr Geoff Pollard, National Executive Officer, Glaucoma Australia and Dr Brian Ang, Consultant Ophthalmologist.
“This is a great opportunity for anyone interested in learning more about this common eye condition,” said Professor Crowston. “In particular, we’ll be exploring current treatment options and what we can do to improve detection rates and management of glaucoma.”
The event will be held at the Royal Victorian Eye and Ear Hospital in East Melbourne and is free to attend, however bookings are essential for catering purposes. Please call 1300 737 757 to book your place or email firstname.lastname@example.org.